Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Cancer, Oncology & Supportive Care

Cancer, Oncology & Supportive Care (168 Condition Guides)

Solid tumor and hematologic oncology overviews, screening guidelines, and supportive symptom management.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Cancer, Oncology & Supportive Care Guides (168)

Clear Filter × Page 4 of 5

Malignant neoplasm of prostate

Malignant neoplasm of prostate—coded clinically as C61 across Cancer & Oncology guidelines—combines targeted/immunotherapy [Malignant neoplasm of prostate C61] with structured follow-up of Pathology / Molecular in Malignant neoplasm of prostate (C61: Genomic Staging) (Guideline-concordant surveillance (C61)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of right main bronchus

Malignant neoplasm of right main bronchus (ICD-10-CM C34.01) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of sigmoid colon

Malignant neoplasm of sigmoid colon (ICD-10-CM C18.7) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of splenic flexure

Malignant neoplasm of splenic flexure—coded clinically as C18.5 across Cancer & Oncology guidelines—combines immunohistochemistry [Malignant neoplasm of splenic flexure C18.5] with structured follow-up of Complete Blood Count in Malignant neoplasm of splenic flexure (C18.5: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (C18.5)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of transverse colon

Malignant neoplasm of transverse colon (ICD-10-CM C18.4) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Malignant neoplasm of trigone of bladder

Malignant neoplasm of trigone of bladder (ICD-10-CM C67.0) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mammography

A mammogram is an x-ray picture of the breast. Health care providers use mammograms to look for early signs of breast cancer that can't be felt during a breast exam. There are two types of mammograms: screening mammograms and diagnostic mammograms. What is a screening mammogram? A screening mammogram is a mammogram usually done for women who have no signs or symptoms of breast cancer. Regular screening mammograms can help reduce the number of deaths from breast cancer among women ages 40 to 74. This is because they can find breast cancer early and treatment can start earlier, maybe before it has spread. But screening mammograms can also have risks.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mastectomy

A mastectomy is surgery to remove part or all of the breast. It's usually done to treat breast cancer by removing the cancer. A mastectomy may be the first treatment option for some types of breast cancer or done after chemotherapy for other types. If you are at a very high risk for breast cancer, sometimes a mastectomy may be done to reduce your risk. What are the different types of mastectomies? There are different types of mastectomies. Each differs in the amount of breast tissue and lymph nodes that are removed. Some types of breast surgery remove the breast skin and the nipple.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Medullary adenocarcinoma

Medullary adenocarcinoma—coded clinically as C80.1 across Cancer & Oncology guidelines—combines immunohistochemistry [Medullary adenocarcinoma C80.1] with structured follow-up of Comprehensive Metabolic & in Medullary adenocarcinoma (C80.1: Organ Function Panel) (Preserved renal/hepatic clearance (C80.1)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Medulloblastoma

Medulloblastoma—coded clinically as C71.6 across Cancer & Oncology guidelines—combines radiation) paired with in Medulloblastoma (C71.6: proactive supportive symptom) with structured follow-up of Complete Blood Count in Medulloblastoma (C71.6: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (C71.6)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Melanoma

Also called: Metastasis • Metastases • Metastatic

Melanoma is the most serious type of skin cancer. Often the first sign of melanoma is a change in the size, shape, color, or feel of a mole. Most melanomas have a black or black-blue area. Melanoma may also appear as a new mole. It may be black, abnormal, or "ugly looking." Thinking of "ABCDE" can help you remember what to watch for: Asymmetry - the shape of one half does not match the other Border - the edges are ragged, blurred or irregular Color - the color is uneven and may include shades of black, brown and tan Diameter - there is a change in size, usually an increase Evolving - the mole has changed over the past few weeks or months Surgery is the first treatment of.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Meningeal tumor

Also called: Meninges • Meningeal • Meninx

Meningeal tumor (ICD-10-CM C70.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mesonephroma - benign

Mesonephroma - benign (ICD-10-CM C56.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Metastatic adenocarcinoma

Also called: Metastasis • Metastases • Metastatic

Metastatic adenocarcinoma (ICD-10-CM C79.9) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Metatypical carcinoma

Metatypical carcinoma—coded clinically as C44.99 across Cancer & Oncology guidelines—combines immunohistochemistry [Metatypical carcinoma C44.99] with structured follow-up of Complete Blood Count in Metatypical carcinoma (C44.99: (ANC, Hemoglobin, Platelets)) (Safe hematologic reserve (C44.99)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Mixed germ cell tumor - malignant

Also called: Fibroid • Leiomyoma • Fibrous

Mixed germ cell tumor - malignant—coded clinically as C56.9 across Cancer & Oncology guidelines—combines radiation) paired with in Mixed germ cell tumor - malignant (C56.9: proactive supportive symptom) with structured follow-up of Pathology / Molecular in Mixed germ cell tumor - malignant (C56.9: Genomic Staging) (Guideline-concordant surveillance (C56.9)).

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Moles

Also called: Nevus • Mole • Molar

Moles are growths on the skin. They happen when pigment cells in the skin, called melanocytes, grow in clusters. Moles are very common. Most people have between 10 and 40 moles. A person may develop new moles from time to time, usually until about age 40. In older people, they tend to fade away. Moles are usually pink, tan or brown. They can be flat or raised. They are usually round or oval and no larger than a pencil eraser. About one out of every ten people has at least one unusual (or atypical) mole that looks different from an ordinary mole. They are called dysplastic nevi. They may be more likely than ordinary moles to develop into melanoma, a type of skin cancer.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Multiple Myeloma

Also called: Plasma-cell myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bones. No one knows the exact causes of multiple myeloma, but it is more common in older people and African Americans. It can run in families.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Myasthenia Gravis

Myasthenia gravis, sometimes called MG, is a chronic (long-lasting) disease that causes weakness in your voluntary muscles. The voluntary muscles are the ones that you can control. They include the muscles you use for: Eye and eyelid movement Facial expressions Chewing Talking Swallowing Breathing Moving your arms and legs You can also have weakness in other muscles. This weakness gets worse with activity, and better with rest. Myasthenia gravis is a type of autoimmune disease. In autoimmune diseases, your immune system attacks the healthy cells of your organs and tissues by mistake.

First-Line Fix: Evidence-based behavioral therapy (CBT/CBT-I), circadian/nerve support, and targeted non-sedating pharmacotherapy

Mycosis fungoides

Mycosis fungoides (ICD-10-CM C84.00) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Nasal Cancer

Also called: Cancer of the nasal cavity • Cancer of the paranasal sinus

Your paranasal sinuses are small hollow spaces around the nose. They are lined with cells that make mucus, which keeps your nose from drying out. The nasal cavity is the passageway just behind your nose. Air passes through it on the way to your throat as you breathe. Cancer of the nasal cavity and paranasal sinuses is rare. You are at greater risk if you are: Male and over 40 years old Exposed to certain workplace chemicals Infected with HPV A smoker There may be no symptoms at first, and later symptoms can be like those of infections. Doctors diagnose nasal cancer with imaging tests, lighted tube-like instruments that look inside the nose, and biopsies.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neuroblastoma

Neuroblastoma is a type of cancer that forms in nerve cells called neuroblasts. Neuroblasts are immature nerve tissue. They normally turn into working nerve cells. But in neuroblastoma, they form a tumor. Neuroblastoma usually begins in the adrenal glands. You have two adrenal glands, one on top of each kidney. The adrenal glands make important hormones that help control heart rate, blood pressure, blood glucose (blood sugar), and the way the body reacts to stress. Neuroblastoma may also begin in the neck, chest or spinal cord. What causes neuroblastoma? Neuroblastoma is caused by changes in your genes.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Neurofibromatosis

Also called: Recklinghausen's disease • von Recklinghausen's disease

Neurofibromatosis is a genetic disorder of the nervous system. It mainly affects how nerve cells form and grow. It causes tumors to grow on nerves. You can get neurofibromatosis from your parents, or it can happen because of a mutation (change) in your genes. Once you have it, you can pass it along to your children. Usually the tumors are benign, but sometimes they can become cancerous. There are three types of neurofibromatosis: Type 1 (NF1) causes skin changes and deformed bones. It usually starts in childhood. Sometimes the symptoms are present at birth. Type 2 (NF2) causes hearing loss, ringing in the ears, and poor balance. Symptoms often start in the teen years.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Nodular sclerosis

Also called: Nodule • Nodular • Multinodular

Nodular sclerosis (ICD-10-CM C81.10) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Oral Cancer

Also called: Fibroid • Leiomyoma • Fibrous

Oral cancer is cancer of the mouth. It is a type of head and neck cancer. Most oral cancers are squamous cell cancers. They begin in the flat cells that cover the surfaces of your mouth, tongue, and lips. The cancer cells may spread into deeper tissue as the cancer grows. Most oral cancers are related to tobacco use, heavy alcohol use, or an HPV infection. Who is more likely to develop oral cancer? Anyone can get oral cancer, but you are more likely to develop it if you: Use tobacco or drink lots of alcohol. Your risk of developing oral cancer is even higher if you do both. Are male. Are over ago 40. Have HPV.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pancreatic Cancer

Also called: Pancreas • Pancreatic • Adenoma

The pancreas is a gland behind your stomach and in front of your spine. It produces the juices that help break down food and the hormones that help control blood sugar levels. Pancreatic cancer usually begins in the cells that produce the juices. Some risk factors for developing pancreatic cancer include: Smoking Long-term diabetes Chronic pancreatitis Certain hereditary disorders Pancreatic cancer is hard to catch early. It doesn't cause symptoms right away. When you do get symptoms, they are often vague or you may not notice them. They include yellowing of the skin and eyes, pain in the abdomen and back, weight loss and fatigue.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Papillary adenocarcinoma

Papillary adenocarcinoma (ICD-10-CM C80.1) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pheochromocytoma

Also called: Metastasis • Metastases • Metastatic

Pheochromocytoma is a rare tumor that usually starts in the cells of one of your adrenal glands. Although they are usually benign, pheochromocytomas often cause the adrenal gland to make too many hormones. This can lead to high blood pressure and cause symptoms such as : Headaches Sweating Pounding of the heart Being shaky Being extremely pale Sometimes pheochromocytoma is part of another condition called multiple endocrine neoplasia syndrome (MEN). People with MEN often have other cancers and other problems involving hormones. Doctors use lab tests and imaging tests to diagnose it. Surgery is the most common treatment.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pilar tumor

Also called: Fibroid • Leiomyoma • Fibrous

Pilar tumor (ICD-10-CM L72.11) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Fragrance-free ceramide barrier repair + targeted topical retinoid, anti-inflammatory, or antimicrobial regimen

Prolymphocytic leukemia (PLL)

Also called: Prolymphocytic leukemia

Prolymphocytic leukemia (PLL) (ICD-10-CM C91.Z0) is evaluated within Cancer, Oncology & Supportive Care using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Prostate Cancer

Also called: Prostate • Prostatic

Cancer is a disease in which cells in the body grow out of control. Prostate cancer begins in the cells of the prostate. The prostate is a gland in the male reproductive system. It lies just below the bladder. It makes fluid that is part of semen. Prostate cancer is one of the most common types of cancer. It often grows very slowly. If it does not spread to other parts of the body, it may not cause serious problems. But sometimes prostate cancer can grow quickly and spread to other parts of the body. This kind of prostate cancer is serious. What causes prostate cancer? Researchers don't know for sure what causes prostate cancer.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Pseudomyxoma peritonei

Designated in federal medical registries as C78.6, Pseudomyxoma peritonei falls under Cancer & Oncology management, where targeted/immunotherapy [Pseudomyxoma peritonei C78.6] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Cancer, Oncology & Supportive Care (168 on dotMD.com?

dotMD.com maps Cancer, Oncology & Supportive Care (168 against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Cancer, Oncology & Supportive Care (168 visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee